DS
RPRX icon

DRW Securities’s Royalty Pharma RPRX Stock Holding History

DRW Securities’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Buy
+6,088
New +$317K 0.01% 550
2025
Q3 		– Sell
-21,556
Closed -$777K – 1578
2025
Q2 		$777K Buy
+21,556
New +$714K 0.02% 341

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DRW Securities's RPRX Position: Q2 2026 in Review

DRW Securities opened a new position in Royalty Pharma (RPRX) in Q2 2026: 6,088 shares worth $341K. The stake represents 0.01% of the portfolio and ranks #550 among its holdings. This is a return to the name: DRW Securities previously reported a position in RPRX as recently as Q2 2025.

DRW Securities first reported a position in RPRX in Q2 2025 and has held it in 2 quarters since. The position peaked at $777K in Q2 2025. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • DRW Securities held 6,088 shares of Royalty Pharma worth $341K as of Q2 2026.
  • Royalty Pharma was a new DRW Securities position in Q2 2026.
  • Royalty Pharma made up 0.01% of DRW Securities's portfolio in Q2 2026, its #550 holding.
  • DRW Securities first reported a position in Royalty Pharma in Q2 2025 and has held it in 2 quarters since.
  • DRW Securities's Royalty Pharma position peaked at $777K in Q2 2025.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.